CORPORATES Alembic Pharmaceuticals receives USFDA approval for Fingolimod capsules; targets $145 million market 12:05 PM IST
CORPORATES Alembic Pharma reports first U.S. prescription sale of Pivya after commercial launch Mar 6, 2026
CORPORATES Alembic Pharma secures USFDA final approval for Lamotrigine Orally Disintegrating Tablets Feb 26, 2026
Alembic Pharma Q3 Results: Revenue jumps 10.8% YoY to Rs 1,876 crore, net profit falls 3.9% Feb 5, 2026
Alembic Pharma shares rally sharply over 6% as Q2 net profit jumps 21% YoY to Rs 185 crore, revenue up 16% Nov 4, 2025